Recently, Shenzhen OxTium Biomedical Technology Co., Ltd. ("OxTium Technology") completed a tens of millions Pre-A+ round of financing, invested by Nanshan Strategic Investment. Nanshan Strategic Investment is the strategic direct investment platform of Shenzhen Nanshan District, focusing on strategic emerging industries and future industries. Previously, OxTium Technology had received tens of millions of RMB in special funds for high-level talents from Shenzhen.
As a pioneer in cutting-edge AI for Science, OxTium Technology has continuously gained favor from multiple investors within months. Sequoia China Seed Fund and CDF-Capital respectively led the Angel+ round and Pre-A round. OxTium Technology has completed cumulative financing of nearly 100 million RMB.
Currently, AI companies and industry demand sides are jointly promoting the ecological supply of "models + AI tools + industry solutions," and OxTium Technology is a typical "participant" in this trend.
At the model level, OxTium Technology has independently developed the cutting-edge bioscience large model GeneLLM, one of the first expert-level large models in the life sciences field in China. Focusing on AI upgrades in the life sciences, it has built a one-stop bioscience research platform BioFord™, a bioscience intelligent agent system BioFord Agent™, and other AI platforms and services. These can be widely applied in basic research, medical diagnosis, biomanufacturing, breeding, environmental monitoring, and other fields, serving clients including leading AI companies, pharmaceutical companies, and universities.
Domestically, the AI for Science field is still in the pre-dawn of an explosion, with vast prospects and far from reaching its ceiling. Against this backdrop, OxTium Technology, with its solid foundation and "hardcore" team, has become a high-quality target attracting market attention. The core members of its founding team are all from the University of Oxford, with a composite background in life sciences and artificial intelligence. They have published over 60 papers in top journals including Nature, demonstrating profound technical expertise.
The industry is about to explode, and early deployment means greater value potential and higher return expectations. Before AI for Science reshapes many industrial and agricultural scenarios and unleashes huge industrial momentum, capital frequently bets on "seed players" like OxTium Technology, akin to buying a ticket to the future, accelerating entry and waiting for the wind to rise.